Search Results - Amador, Yohan

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Nimotuzumab in the Treatment of Inoperable Esophageal Tumors of Epithelial Origin

    Nimotuzumab in the Treatment of Inoperable Esophageal Tumors of Epithelial Origin by González Fernández, Sandra, Amador García, Yohan, Boris Porras, Lucien Gregoria, Mojena Martínez, Liuba, Soler Porro, Luis Laureano, Pish Martí, Gustavo, Fonseca Chon, Liem, Estrada Guerra, Yelec, Álvarez Blanco, Jorge Manuel, Garabito Perdomo, Acralys, Santel Odio, Félix Bárbaro, Varona Vázquez, Luis Alfonso, Ricardo Serrano, Yoel Mario, Chao González, Lisette, Avila Albuerne, Yisel, Sánchez Valdés, Lizet, Viada González, Carmen Elena, Ramos Suzarte, Mayra, Saumell Nápoles, Yaimarelis

    Published in Journal of oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Nimotuzumab Concurrent with Gemcitabine as First-Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma

    Nimotuzumab Concurrent with Gemcitabine as First-Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma by Sánchez, Yamirka, Concepción, Martha L., Amador, Yohan, Piriz, Angel, Rabassa, René, Leyva, Ariel, Arguelles, Odalys, Leblanch, Lisett, Moret, Sheyla, Rivero, Gilberto, Vasallo, Ana L., Martorell, Beatriz, Guerra, Pedro P., Valls, Ana R., Sánchez, Lisset, Saumell, Yaimarelis

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: